Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Cancer Research: April 15
PubMed Central PMCID: PMC6711145
as a targeted therapy to treat patients with HCC whose tumors have an activated FGFR4 signaling pathway
5-Dimethyl-4-(4''-hydroxy-3''-isopropylbenzyl)phenoxy]methylphosphonicAcid
Enoxacin Catalog No.:M9243-10 Cancer Research: April 15Enoxacin is an oral broad spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections and gonorrhea. Enoxacin is a broad spectrum antibacterial agent that is structurally related to nalidixic acid. It acts on DNA gyrase. Insomnia is a common adverse effect. Recently, enoxacin has been shown recently that it may have cancer inhibiting effect. Product information CAS Number: 74011 58 8 Molecular Weight: 320. 32
US$ 1099.50
US$ 44.00
US$ 12004.50
US$ 28.00
US$ 44.10
US$ 34.00
US$ 44.00
US$ 57.00
US$ 65.00
US$ 56.00
US$ 44.00
US$ 30.00
US$ 69.00
US$ 135.00
US$ 1651.50
US$ 1644.50
US$ 44.00
US$ 63.00